Nitric Oxide Involvement in Septic Shock: Do Human Beings behave like Rodents?
暂无分享,去创建一个
[1] J. Parrillo,et al. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. , 1993, The American journal of physiology.
[2] J. Vincent,et al. Nitric oxide production is increased in patients after burn injury. , 1996, The Journal of trauma.
[3] S. Gardiner,et al. Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats , 1995, British journal of pharmacology.
[4] P. Vallance,et al. Induction of NG-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthases? , 1995, The American journal of physiology.
[5] A. Groeneveld,et al. Methylene blue increases myocardial function in septic shock. , 1995, Critical care medicine.
[6] Y. Shiratori,et al. Increased Nitric Oxide in the Exhaled Air of Patients with Decompensated Liver Cirrhosis , 1995, Annals of Internal Medicine.
[7] T. Horio,et al. Increased Nitric Oxide Production in Patients with Hypotension during Hemodialysis , 1995, Annals of Internal Medicine.
[8] T. Hintze,et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. , 1995, Circulation.
[9] R. Cammack,et al. l‐Arginine depletion by arginase reduces nitric oxide production in endotoxic shock: an electron paramagnetic resonance study , 1995, FEBS letters.
[10] J. Carcillo,et al. Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. , 1995, Critical care medicine.
[11] S. Moncada,et al. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. , 1995, Biochemical and biophysical research communications.
[12] A. Dominiczak,et al. Inducible L-arginine/nitric oxide pathway in human internal mammary artery and saphenous vein. , 1995, The American journal of physiology.
[13] M. Currie,et al. Regulation of prostaglandin production by nitric oxide; an in vivo analysis , 1995, British journal of pharmacology.
[14] C. Thiemermann,et al. Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats , 1995, British journal of pharmacology.
[15] R. Busse,et al. Increase in serum NG-hydroxy-L-arginine in rats treated with bacterial lipopolysaccharide. , 1995, European journal of pharmacology.
[16] J. Vincent,et al. Methylene blue administration in septic shock: A clinical trial , 1995 .
[17] M. Hjelm,et al. L-arginine increases exhaled nitric oxide in normal human subjects. , 1995, Clinical science.
[18] P. Howdle,et al. Nitric oxide synthase activity is increased in patients with sepsis syndrome. , 1995, Clinical science.
[19] S. Moncada,et al. L-arginine: nitric oxide pathway in endotoxemia and human septic shock. , 1995, Critical care medicine.
[20] D. Macintyre,et al. Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin. , 1995, The Journal of pharmacology and experimental therapeutics.
[21] N. Blau,et al. Tetrahydrobiopterin as another EDRF in man. , 1994, Biochemical and biophysical research communications.
[22] C. Mitaka,et al. Effects of TNF-alpha on hemodynamic changes and circulating endothelium-derived vasoactive factors in dogs. , 1994, The American journal of physiology.
[23] J. Polak,et al. Expression of inducible nitric oxide in human lung epithelial cells. , 1994, Biochemical and biophysical research communications.
[24] M. Ernst,et al. Nitric oxide synthase: MRNA expression of different isoforms in human monocytes/macrophages , 1994, European journal of immunology.
[25] G. Tiao,et al. Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. , 1994, Surgery.
[26] T. Evans,et al. Nitric oxide synthesis in patients with advanced HIV infection , 1994, Clinical and experimental immunology.
[27] T. Billiar,et al. New insights into the regulation of inducible nitric oxide synthesis. , 1994, The American journal of physiology.
[28] J. Stamler,et al. Methylene blue reverses endotoxin-induced hypotension. , 1994, Circulation research.
[29] S. Moncada,et al. A rapid and simple method for the measurement of nitrite and nitrate in plasma by high performance capillary electrophoresis. , 1994, Biochemical and biophysical research communications.
[30] L. Owen-Schaub,et al. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs. , 1994, Journal of applied physiology.
[31] Y. Courtois,et al. Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines. , 1994, Biochemical and biophysical research communications.
[32] S. Moncada,et al. Effects of a nitric oxide synthase inhibitor in humans with septic shock. , 1994, Cardiovascular research.
[33] J. Vincent,et al. Is endotoxin-induced hypotension related to nitric oxide formation? , 1994, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.
[34] D. Beasley,et al. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. , 1994, The Journal of experimental medicine.
[35] J. Pearson,et al. Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of l‐arginine transport, in activated murine macrophage J774 cells , 1993, British journal of pharmacology.
[36] W. Hsueh,et al. Plasma cyclic guanosine monophosphate in chronic heart failure: Hemodynamic and neurohormonal correlations and response to nitrate therapy , 1993, Clinical pharmacology and therapeutics.
[37] K. Macnaul,et al. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. , 1993, Biochemical and biophysical research communications.
[38] I. Adcock,et al. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. , 1993, Biochemical and biophysical research communications.
[39] V. Laubach,et al. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. , 1993, Biochemistry.
[40] J. Cohen,et al. Evidence of increased nitric oxide production in patients with the sepsis syndrome. , 1993, Circulatory shock.
[41] A. Peitzman,et al. Nitric oxide production is inhibited in trauma patients. , 1993, The Journal of trauma.
[42] J. Michel,et al. Vascular relaxation and cyclic guanosine monophosphate in a rat model of high output heart failure. , 1993, Cardiovascular research.
[43] M. J. Winn,et al. Effects of NG-substituted arginines on coronary vascular function after endotoxin. , 1993, Journal of applied physiology.
[44] A. Macleod,et al. Induction of nitric oxide synthase in human mesangial cells. , 1993, Biochemical and biophysical research communications.
[45] N. Blau,et al. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. , 1993, The Journal of infectious diseases.
[46] C. Nathan,et al. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide , 1993, The Journal of experimental medicine.
[47] J. Balligand,et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. , 1993, The Journal of clinical investigation.
[48] S H Snyder,et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[49] I. Fleming,et al. Influence of endothelium on induction of the L-arginine-nitric oxide pathway in rat aortas. , 1993, The American journal of physiology.
[50] C. Thiemermann,et al. Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock , 1993, British journal of pharmacology.
[51] S. Archer,et al. Measurement of nitric oxide in biological models , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[52] S. Tannenbaum,et al. Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[53] P. Poole‐Wilson,et al. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. , 1992, The American journal of physiology.
[54] C. Natanson,et al. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin , 1992, The Journal of experimental medicine.
[55] Simon C Watkins,et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.
[56] Å. Wennmalm,et al. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin , 1992, British journal of pharmacology.
[57] D. Herndon,et al. Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. , 1992, Journal of applied physiology.
[58] R. Wallace,et al. Discriminatory effects of protein kinase inhibitors and calcium ionophore on endothelial ICAM-1 induction. , 1992, The American journal of physiology.
[59] S. Moncada,et al. Protective and pathological roles of nitric oxide in endotoxin shock. , 1992, Cardiovascular research.
[60] P. Vallance,et al. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock , 1991, The Lancet.
[61] A. Peitzman,et al. Nitrogen oxide levels in patients after trauma and during sepsis. , 1991, Annals of surgery.
[62] N. Cortas,et al. Pharmacokinetic aspects of inorganic nitrate ingestion in man. , 1991, Pharmacology & toxicology.
[63] R. L. Simmons,et al. Modulation of Nitrogen Oxide Synthesis In Vivo: NG‐Monomethyl‐L‐Arginine Inhibits Endotoxin‐Induced Nitrate/Nitrate Biosynthesis While Promoting Hepatic Damage , 1990, Journal of leukocyte biology.
[64] J. Adams,et al. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. , 1990, Biochemical and biophysical research communications.
[65] J. Parratt,et al. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. , 1990, The American journal of physiology.
[66] C. Thiemermann,et al. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. , 1990, European journal of pharmacology.
[67] K. Gersonde,et al. Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome. , 1990, Free radical research communications.
[68] S. Moncada,et al. EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.
[69] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[70] S. Tannenbaum,et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.
[71] W. Boyce,et al. Hypertension and Decreased Renal Blood Flow Following Methylene Blue Injection , 1976, Anesthesia and analgesia.
[72] Carter Vb,et al. The power of words. , 1951, Lancet.